john

Brief Profile

Dr. John Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive background in medicinal chemistry and drug discovery. He is based out of New York, USA and is responsible for providing leadership to Mestastop in the areas of drug discovery and collaboration.

Dr. John Ellingboe

Senior Scientific Advisor

Education:PhD, Organic Chemistry, MIT
Location:New York, NY

Details

 AVP, Wyeth, Pfizer (25+ years)
Senior VP, GVK BIO
 Drug Discovery veteran in US pharma

Mumbai Angels

Pudnaa

Developer

“Mestastop is charting a pioneering and much-needed path to early detection of metastasis. Such work is key to furthering mankind’s understanding of human health”

Dr. D.C Doval

Krishnan D

Developer

“If Mestastop can predict metastasis probability of primary cancer patients, that will be a game changer for doctors”

Dr. A. K Vaid

Doctor

Developer

“Mestastop provides a great opportunity at finding solutions to the unmet medical needs in cancer care”

Dr. A. Kamath

Pudnaa

Developer

“Concept-wise, it is a much-needed approach to address metastasis; looks very interesting and perhaps doable with Arnab’s keen interest and passion”

CIIE

Clifi sinto

Developer

“Mestastop platform will play an instrumental role in changing cancer treatment in India and the world around”